STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance
ConditionST Elevation Myocardial Infarction
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThomas Engstrom
About this trial
The purpose of is study is to investigate whether ischemic postconditioning (iPOST) and intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PCI.
Eligibility criteria
Qualifiers
Age ≥18 years
Acute onset of chest pain with <12 hours duration
STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST depression in 2 or more V1 through V4 leads indicating posterior AMI.
Disqualifiers
None
Trial design
Treatments tested in this trial
- PCI + Ischemic conditioning
- Stent with ultrasound
Treatment groups
2,500 Participants
are divided into 4 treatment groupsSponsors and collaborators
Thomas Engstrom
Lead sponsor
Rigshospitalet, Denmark
Sponsor institution
Source ClinicalTrials.gov